These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7196167)

  • 1. Does evidence of reductive halothane biotransformation correlate with hepatic binding of metabolites in obese patients?
    Bentley JB; Vaughan RW; Cork RC; Gandolfi AJ
    Anesth Analg; 1981 Aug; 60(8):548-51. PubMed ID: 7196167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
    Cousins MJ; Gourlay GK; Knights KM; Hall PD; Lunam CA; O'Brien P
    Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cimetidine on anesthetic metabolism and toxicity.
    Wood M; Uetrecht J; Phythyon JM; Shay S; Sweetman BJ; Shaheen O; Wood AJ
    Anesth Analg; 1986 May; 65(5):481-8. PubMed ID: 3963434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of volatile anesthetics or fentanyl on hepatic function in cirrhotic rats.
    Baden JM; Kundomal YR; Luttropp ME; Maze M; Kosek JC
    Anesth Analg; 1985 Dec; 64(12):1183-8. PubMed ID: 4061900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane hepatotoxicity and reductive metabolism of halothane in acute experimental liver injury in rats.
    Nomura F; Hatano H; Iida S; Ohnishi K
    Anesth Analg; 1988 May; 67(5):448-52. PubMed ID: 3364763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrahepatic biotransformation of halothane and enflurane.
    Blitt CD; Gandolfi AJ; Soltis JJ; Brown BR
    Anesth Analg; 1981 Mar; 60(3):129-32. PubMed ID: 7193988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of enflurane in obese patients.
    Miller MS; Gandolfi AJ; Vaughan RW; Bentley JB
    J Pharmacol Exp Ther; 1980 Nov; 215(2):292-6. PubMed ID: 7441496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver function in patients with mild alcoholic hepatitis, after enflurane, nitrous oxide-narcotic, and spinal anesthesia.
    Zinn SE; Fairley HB; Glenn JD
    Anesth Analg; 1985 May; 64(5):487-90. PubMed ID: 3994010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis.
    Gitlin N
    Am J Gastroenterol; 1982 Jan; 77(1):2-4. PubMed ID: 6801971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic biotransformation and renal function in obese patients during and after methoxyflurane or halothane anesthesia.
    Young SR; Stoelting RK; Peterson C; Madura JA
    Anesthesiology; 1975 Apr; 42(4):451-7. PubMed ID: 1119711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of halothane in guinea pig liver slices.
    Ghantous HN; Fernando J; Gandolfi AJ; Brendel K
    Drug Metab Dispos; 1990; 18(4):514-8. PubMed ID: 1976077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SGOT values following evidence of reductive biotransformation of halothane in man.
    Nawaf K; Stoelting RK
    Anesthesiology; 1979 Aug; 51(2):185-6. PubMed ID: 453631
    [No Abstract]   [Full Text] [Related]  

  • 14. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General anesthesia for morbidly obese patients--an examination of postoperative outcomes.
    Cork RC; Vaughan RW; Bentley JB
    Anesthesiology; 1981 Apr; 54(4):310-3. PubMed ID: 7212331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents.
    Van Dyke RA; Gandolf AJ
    Drug Metab Dispos; 1976; 4(1):40-4. PubMed ID: 3400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane biotransformation in obese and nonobese patients.
    Bentley JB; Vaughan RW; Gandolfi AJ; Cork RC
    Anesthesiology; 1982 Aug; 57(2):94-7. PubMed ID: 7091749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane inhibits metabolism of enflurane in Fischer 344 rats.
    Fish KJ; Rice SA
    Anesthesiology; 1983 Nov; 59(5):417-20. PubMed ID: 6638548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary and biliary excretion of metabolites of halothane in dogs.
    Sakai T; Yoshida H; Fukui A; Takaori M
    Drug Metab Dispos; 1991; 19(2):419-22. PubMed ID: 1676647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of covalently bound halothane metabolites in the hypoxic rat model for halothane hepatotoxicity.
    Gandolfi AJ; Sipes IG; Brown BR
    Fundam Appl Toxicol; 1981; 1(3):255-9. PubMed ID: 7184790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.